| Literature DB >> 30603107 |
Anna Vesty1, Kim Gear2, Kristi Biswas1, Fiona J Radcliff3, Michael W Taylor4,5, Richard G Douglas1.
Abstract
Head and neck squamous cell carcinoma (HNSCC) patients often present with poor oral health, making it difficult to assess the relationship between oral microbes, inflammation, and carcinoma. This study investigates salivary microbes and inflammatory cytokines as biomarkers for HNSCC, with consideration of oral health. Saliva was collected from 30 participants, including 14 HNSCC patients and 16 participants representing both dentally compromised and healthy individuals. Bacterial and fungal communities were analyzed based on 16S rRNA gene and ITS1 amplicon sequencing, respectively, and concentrations of inflammatory cytokines were quantified using a cytometric bead array, with flow cytometry. Diversity-based analyses revealed that the bacterial communities of HNSCC patients were significantly different to those of the healthy control group but not the dentally compromised patients. Fungal communities were dominated by Candida, irrespective of cohort, with Candida albicans comprising ≥96% of fungal sequences in most HNSCC patients. Significantly higher concentrations of interleukin (IL)-1β and IL-8 were detected in HNSCC and dentally compromised patients, when independently compared with healthy controls. IL-1β and IL-8 concentrations were significantly positively correlated with the abundance of C. albicans. Our findings suggest that salivary microbial and inflammatory biomarkers of HNSCC are influenced by oral health.Entities:
Keywords: cytokines; head and neck cancer; oral microbiome; oral mycobiome; saliva
Year: 2018 PMID: 30603107 PMCID: PMC6305924 DOI: 10.1002/cre2.139
Source DB: PubMed Journal: Clin Exp Dent Res ISSN: 2057-4347
Figure 1Genus‐level summary of microbial communities in saliva by disease group. Each bar in (a) reflects the bacterial community in one sample and is aligned with its corresponding fungal community in (b). (a) 30 most abundant bacterial genera (on average) rarefied to 1996 sequences per sample; and (b) five most abundant (on average) fungal genera, with Candida‐assigned sequences identified at operational taxonomic unit level, excluding five healthy control samples that did not meet the fungal rarefication criterion
Figure 2Bray–Curtis dissimilarity nMDS plots by disease group depicting (a) bacterial beta diversity and (b) fungal beta diversity. Ellipses represent a 95% confidence interval for each disease group. Data that failed subsampling thresholds were excluded, therefore, no ellipse was calculated for healthy controls (n = 2) in (b)
Summary of detectable inflammatory cytokines
| HNSCC | Dentally compromised | Healthy | |
|---|---|---|---|
| IL‐1 | 11/14 (79%) | 9/9 (100%) | 6/7 (86%) |
| Concentration IL‐1 | 5.1 ± 0.9 | 5.2 ± 1.5 | 3.5 ± 0.9 |
| IL‐6 | 6/14 (43%) | 1/9 (11%) | 0/7 (0%) |
| Concentration IL‐6 | −0.8 ± 1.2 | −0.1 ± N/A | N/A |
| IL‐8 | 13/14 (93%) | 9/9 (100%) | 6/7 (86%) |
| Concentration IL‐8 | 7.2 ± 1.4 | 7.1 ± 1.2 | 5.3 ± 2.0 |
Number of patients cytokine detected in/total patients in disease group.
Cytokine concentration (log pg/ml; mean ± SD).
Two‐way ANOVA summary of IL‐1β and IL‐8 concentration comparisons
| HNSCC versus healthy | Dentally compromised versus healthy | HNSCC versus dentally compromised | |
|---|---|---|---|
| Difference IL‐1 | 5.1 | 5.4 | 0.93 |
|
|
|
|
|
| Difference IL‐8 | 6.7 | 6.5 | 1.0 |
|
|
|
|
|
Fold difference in cytokine concentration A to B (A vs. B).
Significant p values expressed in bold (α = 0.05). Tukey's post‐hoc test, 95% confidence interval.
Figure 3Correlation matrix visualizing significant correlations (p < 0.01) between microbial relative abundance data and the concentrations of IL‐1β and IL‐8. Positive correlations are visualized in shades of red and negative correlations in shades of blue; correlations where the p value was ≥0.01 are left blank. Correlations are ordered by hierarchical clustering, with clusters outlined